| Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins S Boudina, S Sena, H Theobald, X Sheng, JJ Wright, XX Hu, S Aziz, ... Diabetes 56 (10), 2457-2466, 2007 | 689 | 2007 |
| Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart S Boudina, H Bugger, S Sena, BT O'Neill, VG Zaha, O Ilkun, JJ Wright, ... Circulation 119 (9), 1272-1283, 2009 | 329 | 2009 |
| Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance CJ Lelliott, G Medina-Gomez, N Petrovic, A Kis, HM Feldmann, M Bjursell, ... PLoS biology 4 (11), e369, 2006 | 322 | 2006 |
| AMP-activated protein kinase regulation and biological actions in the heart VG Zaha, LH Young Circulation research 111 (6), 800-814, 2012 | 304 | 2012 |
| Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3 H Bugger, S Boudina, XX Hu, J Tuinei, VG Zaha, HA Theobald, UJ Yun, ... Diabetes 57 (11), 2924-2932, 2008 | 212 | 2008 |
| A small molecule AMPK activator protects the heart against ischemia–reperfusion injury AS Kim, EJ Miller, TM Wright, J Li, D Qi, K Atsina, V Zaha, K Sakamoto, ... Journal of molecular and cellular cardiology 51 (1), 24-32, 2011 | 192 | 2011 |
| PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy C Riehle, AR Wende, VG Zaha, KM Pires, B Wayment, C Olsen, H Bugger, ... Circulation research 109 (7), 783-793, 2011 | 174 | 2011 |
| Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology JA Thompson, BJ Schneider, J Brahmer, A Achufusi, P Armand, ... Journal of the National Comprehensive Cancer Network 20 (4), 387-405, 2022 | 173 | 2022 |
| A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy BT O'Neill, J Kim, AR Wende, HA Theobald, J Tuinei, J Buchanan, A Guo, ... Cell metabolism 6 (4), 294-306, 2007 | 161 | 2007 |
| Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action C Graveleau, VG Zaha, A Mohajer, RR Banerjee, N Dudley-Rucker, ... Journal of biological chemistry 280 (36), 31679-31685, 2005 | 127 | 2005 |
| Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin DJ Durgan, JK Smith, MA Hotze, O Egbejimi, KD Cuthbert, VG Zaha, ... American Journal of Physiology-Heart and Circulatory Physiology 290 (6 …, 2006 | 113 | 2006 |
| Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society JD Mitchell, DA Cehic, M Morgia, C Bergom, J Toohey, PA Guerrero, ... Cardio Oncology 3 (3), 360-380, 2021 | 112 | 2021 |
| Efficacy of neurohormonal therapies in preventing cardiotoxicity in patients with cancer undergoing chemotherapy M Vaduganathan, SA Hirji, A Qamar, N Bajaj, A Gupta, VG Zaha, ... Cardio Oncology 1 (1), 54-65, 2019 | 109 | 2019 |
| Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives S Ganatra, JR Carver, SS Hayek, B Ky, MJ Leja, DJ Lenihan, ... Journal of the American College of Cardiology 74 (25), 3153-3163, 2019 | 83 | 2019 |
| AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia VG Zaha, D Qi, KN Su, M Palmeri, HY Lee, X Hu, X Wu, GI Shulman, ... Journal of molecular and cellular cardiology 91, 104-113, 2016 | 83 | 2016 |
| Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density AP McQueen, D Zhang, P Hu, LA Swenson, Y Yang, VG Zaha, ... Journal of molecular and cellular cardiology 39 (6), 882-892, 2005 | 73 | 2005 |
| Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction GG Schiattarella, F Altamirano, SY Kim, D Tong, A Ferdous, H Piristine, ... Nature communications 12 (1), 1684, 2021 | 67 | 2021 |
| Cardio-Oncology Education and Training: JACC Council Perspectives JA Alvarez-Cardona, J Ray, J Carver, V Zaha, R Cheng, E Yang, ... Journal of the American College of Cardiology 76 (19), 2267-2281, 2020 | 50 | 2020 |
| Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ... The Lancet Diabetes & Endocrinology 10 (1), 35-45, 2022 | 40 | 2022 |
| Cardio-immuno-oncology VG Zaha, WC Meijers, J Moslehi Circulation 141 (2), 87-89, 2020 | 39 | 2020 |
